IRIDEX CORPORATION - COMMON STOCK

Iridex Reports Second Quarter 2023 Financial Results

10 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex to Report Second Quarter Financial Results on August 10, 2023

27 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Reports First Quarter 2023 Financial Results

11 май 2023 16:05:01 Источник Nasdaq GlobeNewswire

Iridex to Report First Quarter Financial Results on May 11, 2023

27 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

09 мар 2023 16:05:01 Источник Nasdaq GlobeNewswire

Iridex to Present at the 35th Annual Roth Conference

07 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Introduces New Research and Showcases Five Events at the AGS Meeting

02 мар 2023 09:00:01 Источник Nasdaq GlobeNewswire

Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

23 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022

10 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Iridex to Participate in Fireside Chat with Stifel Equity Research

06 дек 2022 17:07:24 Источник Nasdaq GlobeNewswire

Iridex Announces Record Third Quarter 2022 Financial Results

10 ноя 2022 16:05:02 Источник Nasdaq GlobeNewswire

Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022

27 окт 2022 16:05:01 Источник Nasdaq GlobeNewswire

Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022

29 сен 2022 16:05:00 Источник Nasdaq GlobeNewswire

Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

18 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Announces Second Quarter 2022 Financial Results

15 авг 2022 16:05:02 Источник Nasdaq GlobeNewswire

Iridex to Report Second Quarter 2022 Financial Results on August 15, 2022

01 авг 2022 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China

14 июн 2022 09:21:43 Источник Nasdaq GlobeNewswire

Iridex Announces First Quarter 2022 Financial Results

12 май 2022 16:05:02 Источник Nasdaq GlobeNewswire

Iridex to Report First Quarter 2022 Financial Results on May 12, 2022

28 апр 2022 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Announces the Appointment of Beverly Huss to its Board of Directors

21 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire